# Session: sub_61089f36:sess_f987ef91

- **subagent_id**: `sub_61089f36`
- **subagent_name**: `regulatory-analyst`
- **session_id**: `sess_f987ef91`
- **model_key**: `llm`
- **model_id**: `gemma-4-31b-it`
- **provider**: `openai_compat`
- **tools_granted**: `["Read", "Glob"]`
- **accessible_paths**: `["/playpen2/xkaiwen/smbench_results/exp/local-gemma-31b/run_gemmalane2_3256605/run_1780856529_73f293/s_clinical_trial_protocol/work/protocols/v3_amendments.md", "/playpen2/xkaiwen/smbench_results/exp/local-gemma-31b/run_gemmalane2_3256605/run_1780856529_73f293/s_clinical_trial_protocol/work/regulations"]`
- **context_size_max**: `59168`

## System Prompt

```
You are a clinical trial regulatory specialist. Your task is to extract precise recruitment targets and compliance requirements from trial protocols and regulatory documents. Provide factual, verbatim-supported notes.
```

## Timeline

## Turn 1 — user
Please read the following:
1. `/playpen2/xkaiwen/smbench_results/exp/local-gemma-31b/run_gemmalane2_3256605/run_1780856529_73f293/s_clinical_trial_protocol/work/protocols/v3_amendments.md` (since I couldn't grant the full protocols folder, I've given you this file which contains the recruitment targ…[truncated 437 chars]

> _system-reminder_: Context usage: 1056/100000 tokens (1%).

## Turn 2 — assistant
### Tool Call: `Read`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-gemma-31b/run_gemmalane2_3256605/run_1780856529_73f293/s_clinical_trial_protocol/work/protocols/v3_amendments.md`

### Tool Call: `Glob`
- **pattern**: `/playpen2/xkaiwen/smbench_results/exp/local-gemma-31b/run_gemmalane2_3256605/run_1780856529_73f293/s_clinical_trial_protocol/work/regulations/*.pdf`

## Turn 3 — tool_result
_tool_call_id_: `chatcmpl-tool-a3265080ed754ab5`

1	# Protocol Amendments — TR-2026-PHII-091 v3
2	
3	## Summary of Changes from v2 → v3
4	
5	This document lists all amendments incorporated into the v3 protocol.
6	All amendments are **binding**; the v3 docx is the authoritative consolidated text.
7	
8	### Amendment 3.1 — CN Eligibility Criteria
9	- …[truncated 1041 chars]

## Turn 4 — tool_result
_tool_call_id_: `chatcmpl-tool-bff55d20be02958b`

tool Glob raised: Non-relative patterns are unsupported

## Turn 5 — assistant
### Tool Call: `Glob`
- **path**: `/playpen2/xkaiwen/smbench_results/exp/local-gemma-31b/run_gemmalane2_3256605/run_1780856529_73f293/s_clinical_trial_protocol/work/regulations/`
- **pattern**: `*.pdf`

## Turn 6 — tool_result
_tool_call_id_: `chatcmpl-tool-8223c8b0becbff06`

/playpen2/xkaiwen/smbench_results/exp/local-gemma-31b/run_gemmalane2_3256605/run_1780856529_73f293/s_clinical_trial_protocol/work/regulations/us_fda_2026.pdf
/playpen2/xkaiwen/smbench_results/exp/local-gemma-31b/run_gemmalane2_3256605/run_1780856529_73f293/s_clinical_trial_protocol/work/regulations/…[truncated 174 chars]

## Turn 7 — assistant
### Tool Call: `Read`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-gemma-31b/run_gemmalane2_3256605/run_1780856529_73f293/s_clinical_trial_protocol/work/regulations/cn_nmpa_2026.pdf`

### Tool Call: `Read`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-gemma-31b/run_gemmalane2_3256605/run_1780856529_73f293/s_clinical_trial_protocol/work/regulations/eu_ema_2026.pdf`

### Tool Call: `Read`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-gemma-31b/run_gemmalane2_3256605/run_1780856529_73f293/s_clinical_trial_protocol/work/regulations/us_fda_2026.pdf`

## Turn 8 — tool_result
_tool_call_id_: `chatcmpl-tool-bc556cbe2385e224`

parsed text too large for a single Read: 697829 bytes >= 262144-byte hard cap. Either pass `offset` + `limit` to page through a specific slice, or delegate the full read to an `llm` subagent (CreateSubagent + RunSubagent) and have it return a summary.

## Turn 9 — tool_result
_tool_call_id_: `chatcmpl-tool-9dfb6ccbb25af4ea`

parsed text too large for a single Read: 650508 bytes >= 262144-byte hard cap. Either pass `offset` + `limit` to page through a specific slice, or delegate the full read to an `llm` subagent (CreateSubagent + RunSubagent) and have it return a summary.

## Turn 10 — tool_result
_tool_call_id_: `chatcmpl-tool-ac2a6e743ff45bb0`

parsed text too large for a single Read: 603298 bytes >= 262144-byte hard cap. Either pass `offset` + `limit` to page through a specific slice, or delegate the full read to an `llm` subagent (CreateSubagent + RunSubagent) and have it return a summary.

## Turn 11 — assistant
### Tool Call: `Read`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-gemma-31b/run_gemmalane2_3256605/run_1780856529_73f293/s_clinical_trial_protocol/work/regulations/cn_nmpa_2026.pdf`
- **limit**: `100`
- **offset**: `0`

### Tool Call: `Read`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-gemma-31b/run_gemmalane2_3256605/run_1780856529_73f293/s_clinical_trial_protocol/work/regulations/eu_ema_2026.pdf`
- **limit**: `100`
- **offset**: `0`

### Tool Call: `Read`
- **file_path**: `/playpen2/xkaiwen/smbench_results/exp/local-gemma-31b/run_gemmalane2_3256605/run_1780856529_73f293/s_clinical_trial_protocol/work/regulations/us_fda_2026.pdf`
- **limit**: `100`
- **offset**: `0`

## Turn 12 — tool_result
_tool_call_id_: `chatcmpl-tool-ac257e034b7a3e44`

1	--- Page 1 ---
2	National Medical Products Administration (NMPA)
3	Good Clinical Practice (GCP) Guidelines — 2026 Edition
4	NMPA Order No. 86 (revised 2026)  |  ■■■■■■■■■■■ 86 ■■2026 ■■■■■
5	Effective: 2026-03-01
6	CHAPTER I — GENERAL PROVISIONS / ■■■ ■■
7	Scope: These guidelines apply to all clin…[truncated 93410 chars]

## Turn 13 — tool_result
_tool_call_id_: `chatcmpl-tool-9baba0c31b810031`

1	--- Page 1 ---
2	European Medicines Agency (EMA)
3	Clinical Trials Guideline — EMA/CHMP/ICH/135/1995 (rev. 2026)
4	Incorporating ICH E6(R3) Good Clinical Practice
5	Effective: 2026-01-15
6	SECTION I — SCOPE AND PRINCIPLES
7	This guideline applies to all clinical trials submitted via CTIS under
8	R…[truncated 93258 chars]

## Turn 14 — tool_result
_tool_call_id_: `chatcmpl-tool-b57529618b635f52`

1	--- Page 1 ---
2	U.S. Food and Drug Administration (FDA)
3	21 CFR Part 312 — Investigational New Drug Application (IND)
4	Incorporating ICH E6(R3) Good Clinical Practice Guidelines
5	Revised: 2026-02-01
6	SUBPART A — GENERAL PROVISIONS
7	Applicable to IND TR-2026-PHII-091-IND-4821 for compound-X42…[truncated 93098 chars]

> _system-reminder_: You have just crossed the 50% threshold of your context window (58695/100000 tokens). Consolidate context, summarise long subagent transcripts in your own words, and avoid redundant exploration.

## Turn 15 — assistant
**content**:

Based on the provided documents, here are the recruitment targets and key compliance requirements:

### **Recruitment Targets**
(Source: `/playpen2/xkaiwen/smbench_results/exp/local-gemma-31b/run_gemmalane2_3256605/run_1780856529_73f293/s_clinical_trial_protocol/work/protocols/v3_amendments.md`)

* …[truncated 1120 chars]
